Men had greater risk for recurrent venous thromboembolism than women

November 2004
ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p78
Academic Journal
The article addresses the question whether the risk for recurrent venous thromboembolism (VTE) differs between men and women. The study was conducted on 826 patients > 18 years of age (mean age 48 y, 55% women) who had a first episode of VTE and had been treated with oral anticoagulants for 3 months. Patients had received standard heparin at doses designed to keep die activated partial thromboplastin time 1.5 to 2.0 times that of the control value or had received subcutaneous low-molecular-weight heparin at therapeutic doses. The study found that after a first episode of venous thromboembolism, men were at greater risk than women for a recurrent episode.


Related Articles

  • COMMENTARY: Men had greater risk for recurrent venous thromboembolism than women. White, Richard H. // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p78 

    The article presents a commentary on the study, which concluded that Men had greater risk for recurrent venous thromboembolism (VTE) than women. Based on this study, it is still not clear exactly which women and which men are at such high risk for recurrent thromboembolism that they are...

  • Eptacog-α.  // Reactions Weekly;3/20/2010, Issue 1293, p23 

    The article describes three cases of women who developed deep vein thrombosis, cerebral ischaemia and pulmonary embolism, respectively, after receiving eptacog-α for obstetric haemorrhage.

  • Detecting thrombophilia in ob/gyn patients. Katz, Vern L. // Contemporary OB/GYN;Oct2002, Vol. 47 Issue 10, p68 

    Discusses thrombophilia, a group of common inherited and acquired coagulopathies, in order to help obstetricians and gynecologists identify patients prone to thrombosis and fetal loss. Examples of pregnancy outcomes associated with thrombophilia; Principal physiologic anticoagulant mechanisms...

  • Systemic Venous Thrombosis after Recombinant Factor VIIa. Mahmoud, Amr; Al-Ruzzeh, Sharif; McKeague, Helena; Cross, Mike // Texas Heart Institute Journal;2007, Vol. 34 Issue 4, p485 

    Recombinant factor VIIa has been licensed in the United Kingdom since 1996 for the control of bleeding in hemophilic patients who are actively bleeding or are about to undergo surgery. Medical practitioners are also applying recombinant factor VIIa toward the control of bleeding in patients...

  • THE 125I LABELED FIBRINOGEN TEST IN THE DIAGNOSIS OF POSTOPERATIVE THROMBOPHLEBITIS. Covey, Thomas H.; Sherman, Laurence // Angiology;Jan1974, Vol. 25 Issue 1, p61 

    The 125I fibrinogen test is a sensitive indicator of early venous thrombosis in the calf and lower thigh. It is a safe, noninvasive, technique, which can be performed by a trained technician with daily monitoring, using easily portable equipment. These characteristics make it an extremely...

  • Mouse models of focal arterial and venous thrombosis. Dörffler-Melly, Janine; Schwarte, Lothar A.; Ince, Can; Levi, Marcel // Basic Research in Cardiology;Nov2000, Vol. 95 Issue 6, p503 

    Mouse models of arterial and venous thrombosis have gained increasing interest over the last 15 years, due to direct availability of a growing number of genetically modified mice, improved technical feasibility, standardization of new models of local thrombosis, and low maintenance costs. In...

  • Prevalence of factor V Leiden mutation in patients with thrombosis in Tunisia. Ajem, A.; Slama, A.; Slama, F. B. H.; Mehjoub, T. // Eastern Mediterranean Health Journal;nov/dic2009, Vol. 15 Issue 6, p1483 

    This study determined the prevalence of inherited factor V Leiden mutation in a group of 128 thrombosis patients (102 with venous thrombosis and 26 with arterial thrombosis) attending a hospital in Sousse, Tunisia, and a control group of 100 with no history of thrombosis. Using an...

  • Diagnosis of deep vein thrombosis: results of a survey. Negus, David // Journal of the Royal Society of Medicine;Nov1978, Vol. 71 Issue 11, p796 

    The article presents a result of a survey, diagnosing deep vein thrombosis. At the said survey, most surgeons who are provided with questionnaires, stated that they or their junior staff regularly examined the legs of all postoperative patients. The next series of questions are concerned on the...

  • Elevated Factor IX Activity Is Associated With an Increased Odds Ratio for Both Arterial and Venous Thrombotic Events. Heikal, Nahla M.; Murphy, Karla K.; Crist, Ronda A.; Wilson, Andrew R.; Rodgers, George M.; Smock, Kristi J. // American Journal of Clinical Pathology;Nov2013, Vol. 140 Issue 5, p680 

    Objectives: Elevations of factor IX (FIX) are thought to contribute to thrombotic risk, but this has not been well characterized. We retrospectively sought to determine whether elevated FIX levels are a risk factor for thrombosis in 81 adult subjects younger than 65 years (mean, 47 years) who...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics